On January 1, 2025, a 2.8% cut to Medicare physician reimbursement went into effect. The cut followed a 1.68% cut from 2024, while the cost of running a medical practice continues to rise due to ...

The Association for Clinical Oncology (ASCO) has signed on to a joint letter to Congressional leaders about the impact of potential Medicaid cuts on access to cancer care for children. Led by the ...

The Conquer Cancer Patient Advocate Award Program helps patient advocates attend ASCO Meetings to learn of important advances in their areas of interest. As of July 2024, more than 1,150 patient ...

To continue, please click on one of the buttons below or access other content through the navigation menu or search.

ASCO is committed to promoting prevention science and integrating evidence-based prevention strategies into oncology practice. ASCO’s prevention goals are to promote clinical, behavioral, and ...

The American Society of Clinical Oncology (ASCO) is a professional oncology society committed to conquering cancer through research, education, prevention, and the delivery of high-quality patient ...

Throughout the year, members can sign-up to participate in virtual meetings focused on specific training or career topics. Members can select from a list of mentors per meeting topic. At the end of ...

Cancer research is the core of ASCO’s mission and cancer cannot be conquered without continued robust federal investment for biomedical research through the National Institutes of Health (NIH) and the ...

The Resilience Skills Training Program aims to improve physician wellness in oncology through a proactive approach. The program targets current trainees to help create a culture change surrounding ...

To learn more about the Oncology Medical Home standards and ASCO Certified recognition from ASCO, please click the button below and submit your questions. ASCO Certified has launched a new application ...

“The TALAPRO-2 study showed a significant improvement in overall survival in men with mCRPC treated with the combination of talazoparib and enzalutamide whether they had HRR gene alterations. In this ...

Founded in 1964, the American Society of Clinical Oncology is the world's leading professional organization for physicians and oncology professionals caring for people with cancer.